North America Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Design (Single Chamber and Multi-chamber), Application (Cancer, Diabetes, Autoimmune Disease, Infectious diseases, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel)
The North America prefilled syringe market was valued at US$ 2,992.69 million in 2022 and is expected to reach US$ 6,783.62 million by 2030; it is estimated to record a CAGR of 10.8% from 2022 to 2030.
Increasing Prevalence of Chronic Disorders Fuels North America Prefilled Syringe Market
The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. The emerging markets will be hit hardest, as a population explosion is expected in developing countries. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and others. Diabetes is one of the major global health issues of the 21st century. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to reach 62 million by 2045. The increase in disease prevalence is approximated to be 35% during the projection period.
Other chronic conditions such as Crohn's disease, multiple sclerosis, and cardiovascular disorders require frequent drug administration for disease management and treatment. As per the WHO, cardiovascular disorders are the leading cause of death-nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become a new standard for injectable drug delivery among large patient populations globally. Moreover, these prefilled syringes can be used by a large patient population with minimal training and do not require constant assistance from healthcare professionals, owing to which prefilled syringes are adopted largely in professional healthcare environments as well as home healthcare settings, thereby driving the prefilled syringes market growth.
North America Prefilled Syringe Market Overview
The North America prefilled syringes market is segmented into the US, Canada, and Mexico. The growth of the prefilled syringes market in the region is mainly due to the increased adoption of self-injecting parenteral devices and a surge in home healthcare to treat chronic diseases in the region.
According to the Diabetes Research Institute, the number of people with diabetes in the US was ~37.3 million (11.3% of the population) in 2022. Nearly 28.7 million people in the US were diagnosed with diabetes, and approximately 8.6 million people have undiagnosed diabetes. Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2020, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to Yale researchers, in 2022, ~30 million people in the US have diabetes, and about 7 million require daily insulin.
There is an increase in the demand for infertility treatment in the US. According to the CDC, in 2022, ~22% married couples, with women aged above 30 years, have problems in conceiving their first child. To overcome with infertility issues, various treatments are available in the market through prefilled syringes. In July 2023, Fresenius Kabi launched Ganirelix Acetate Injection, a generic fertility drug, in 250 mcg0.5 ml prefilled syringes as part of the company's expansion in women's health. Therefore, the increasing prevalence of diabetes and other disorders, along with surge in product launches, is expected to drive the growth of prefilled syringes market in the US.
North America Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)
North America Prefilled Syringe Market Segmentation
The North America prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.
Based on type, the North America prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger North America prefilled syringe market share in 2022.
Based on material, the North America prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger North America prefilled syringe share in 2022.
Based on designs, the North America prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger North America prefilled syringe share in 2022.
In terms of application, the North America prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest North America prefilled syringe share in 2022.
By distribution channel, the North America prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest North America prefilled syringe market share in 2022.
Based on country, the North America prefilled syringe market is categorized into the US, Canada, and Mexico. The US dominated the North America prefilled syringe market in 2022.
B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the North America prefilled syringe market.
Increasing Prevalence of Chronic Disorders Fuels North America Prefilled Syringe Market
The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. The emerging markets will be hit hardest, as a population explosion is expected in developing countries. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and others. Diabetes is one of the major global health issues of the 21st century. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to reach 62 million by 2045. The increase in disease prevalence is approximated to be 35% during the projection period.
Other chronic conditions such as Crohn's disease, multiple sclerosis, and cardiovascular disorders require frequent drug administration for disease management and treatment. As per the WHO, cardiovascular disorders are the leading cause of death-nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become a new standard for injectable drug delivery among large patient populations globally. Moreover, these prefilled syringes can be used by a large patient population with minimal training and do not require constant assistance from healthcare professionals, owing to which prefilled syringes are adopted largely in professional healthcare environments as well as home healthcare settings, thereby driving the prefilled syringes market growth.
North America Prefilled Syringe Market Overview
The North America prefilled syringes market is segmented into the US, Canada, and Mexico. The growth of the prefilled syringes market in the region is mainly due to the increased adoption of self-injecting parenteral devices and a surge in home healthcare to treat chronic diseases in the region.
According to the Diabetes Research Institute, the number of people with diabetes in the US was ~37.3 million (11.3% of the population) in 2022. Nearly 28.7 million people in the US were diagnosed with diabetes, and approximately 8.6 million people have undiagnosed diabetes. Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2020, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to Yale researchers, in 2022, ~30 million people in the US have diabetes, and about 7 million require daily insulin.
There is an increase in the demand for infertility treatment in the US. According to the CDC, in 2022, ~22% married couples, with women aged above 30 years, have problems in conceiving their first child. To overcome with infertility issues, various treatments are available in the market through prefilled syringes. In July 2023, Fresenius Kabi launched Ganirelix Acetate Injection, a generic fertility drug, in 250 mcg0.5 ml prefilled syringes as part of the company's expansion in women's health. Therefore, the increasing prevalence of diabetes and other disorders, along with surge in product launches, is expected to drive the growth of prefilled syringes market in the US.
North America Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)
North America Prefilled Syringe Market Segmentation
The North America prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.
Based on type, the North America prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger North America prefilled syringe market share in 2022.
Based on material, the North America prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger North America prefilled syringe share in 2022.
Based on designs, the North America prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger North America prefilled syringe share in 2022.
In terms of application, the North America prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest North America prefilled syringe share in 2022.
By distribution channel, the North America prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest North America prefilled syringe market share in 2022.
Based on country, the North America prefilled syringe market is categorized into the US, Canada, and Mexico. The US dominated the North America prefilled syringe market in 2022.
B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the North America prefilled syringe market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA PREFILLED SYRINGE MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Disorders
4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
4.2.1 Increasing Product Recalls
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis
5. PREFILLED SYRINGE MARKET - NORTH AMERICA MARKET ANALYSIS
5.1 North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
6. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY TYPE
6.1 Overview
6.2 North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
6.3.1 Overview
6.3.2 Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
6.4.1 Overview
6.4.2 Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY MATERIAL
7.1 Overview
7.2 North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
7.3.1 Overview
7.3.2 Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
7.4.1 Overview
7.4.2 Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DESIGN
8.1 Overview
8.2 North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
8.3.1 Overview
8.3.2 Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
8.4.1 Overview
8.4.2 Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
9.1 Overview
9.2 North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
9.3.1 Overview
9.3.2 Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
9.6.1 Overview
9.6.2 Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
11. NORTH AMERICA PREFILLED SYRINGE MARKET - COUNTRY ANALYSIS
11.1 North America Prefilled Syringes Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Prefilled Syringes Market, by Country
11.1.2.1 US
11.1.2.1.1 US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1.2 US: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.1.3 US: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.1.4 US: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.1.5 US: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.1.6 US: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.2.2 Canada
11.1.2.2.1 Overview
11.1.2.2.2 Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2.3 Canada: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.2.4 Canada: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.2.5 Canada: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.2.6 Canada: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.2.7 Canada: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.2.3 Mexico
11.1.2.3.1 Overview
11.1.2.3.2 Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.3.3 Mexico: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.3.4 Mexico: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.3.5 Mexico: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.3.6 Mexico: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.3.7 Mexico: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 B Braun SE
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Gerresheimer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Schott AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Nipro Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Becton Dickinson and Co
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Baxter International Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Terumo Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ypsomed Holding AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA PREFILLED SYRINGE MARKET - KEY INDUSTRY DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Disorders
4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
4.2 Market Restraints
4.2.1 Increasing Product Recalls
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Ongoing Innovation in Prefilled Syringes
4.5 Impact Analysis
5. PREFILLED SYRINGE MARKET - NORTH AMERICA MARKET ANALYSIS
5.1 North America Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030
6. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY TYPE
6.1 Overview
6.2 North America Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Disposable Prefilled Syringes
6.3.1 Overview
6.3.2 Disposable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Reusable Prefilled Syringes
6.4.1 Overview
6.4.2 Reusable Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY MATERIAL
7.1 Overview
7.2 North America Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
7.3 Glass Prefilled Syringes
7.3.1 Overview
7.3.2 Glass Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Plastic Prefilled Syringes
7.4.1 Overview
7.4.2 Plastic Prefilled Syringes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DESIGN
8.1 Overview
8.2 North America Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
8.3 Single Chamber
8.3.1 Overview
8.3.2 Single Chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Multi-chamber
8.4.1 Overview
8.4.2 Multi-chamber: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
9.1 Overview
9.2 North America Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Cancer
9.3.1 Overview
9.3.2 Cancer: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Infectious Diseases
9.6.1 Overview
9.6.2 Infectious Diseases: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10. NORTH AMERICA PREFILLED SYRINGE MARKET - REVENUE AND FORECAST TO 2030 - BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 North America Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: North America Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
11. NORTH AMERICA PREFILLED SYRINGE MARKET - COUNTRY ANALYSIS
11.1 North America Prefilled Syringes Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Prefilled Syringes Market, by Country
11.1.2.1 US
11.1.2.1.1 US Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.1.2 US: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.1.3 US: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.1.4 US: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.1.5 US: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.1.6 US: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.2.2 Canada
11.1.2.2.1 Overview
11.1.2.2.2 Canada Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2.3 Canada: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.2.4 Canada: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.2.5 Canada: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.2.6 Canada: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.2.7 Canada: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
11.1.2.3 Mexico
11.1.2.3.1 Overview
11.1.2.3.2 Mexico Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.3.3 Mexico: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
11.1.2.3.4 Mexico: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
11.1.2.3.5 Mexico: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
11.1.2.3.6 Mexico: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
11.1.2.3.7 Mexico: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 B Braun SE
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Shandong Weigao Group Medical Polymer Co Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Gerresheimer AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Schott AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Nipro Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Becton Dickinson and Co
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Baxter International Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Terumo Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ypsomed Holding AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. APPENDIX
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Prefilled Syringe Market Segmentation
Table 2. US Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Prefilled Syringe Market
Table 1. North America Prefilled Syringe Market Segmentation
Table 2. US Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Prefilled Syringes Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Prefilled Syringes Market, by Material - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Prefilled Syringes Market, by Design - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Prefilled Syringes Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Prefilled Syringes Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Prefilled Syringe Market
